Johan Richter

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Johan Richter, Joëlle Guilhot, Franz Gruber et al. · The Lancet Oncology · 2018 · 611 citations · Full text

Medicine, Oncology, Pharmacology +11

Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Andreas Hochhaus, Gianantonio Rosti, F-X Mahon et al. · Annals of Oncology · 2017 · 342 citations

Medicine, Hematology, Oncology +14

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

Mette Ilander, Ulla Olsson‐Strömberg, Heinrich Schlums et al. · Leukemia · 2016 · 247 citations · Full text

Medicine, Hematology, Immunology +14

Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008

Magnus Björkholm, Lotta Ohm, Sandra Eloranta et al. · Journal of Clinical Oncology · 2011 · 214 citations

Medicine, Oncology, Pharmacology +13

Murine models of acute neuronopathic Gaucher disease

Ida Enquist, Christophe Lo Bianco, Andreas Ooka et al. · Proceedings of the National Academy of Sciences · 2007 · 198 citations

Life Sciences, Genetics, Pathology +17